Prediabetic markers in children with stress hyperglycemia

Donna M. Bhisitkul, Aaron I. Vinik, Ardythe L. Morrow, Jin Xiong She, Justine Shults, Alvin C. Powers, Noel K. Maclaren

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Previous studies have shown that children with stress hyperglycemia have an increased risk for development of type I or insulin- dependent diabetes mellitus. Objective: To determine whether stress hyperglycemia in prospectively screened pediatric patients represents a prediabetic state. Designs: Prospective, cohort analytic study. Setting: The Children's Hospital of the King's Daughters is an urban pediatric emergency department at a tertiary care, university-based children's hospital in Norfolk, Va. Patient Population: All patients who required a venipuncture for evaluation of an acute illness or injury from October 1992 through March 1993 were screened prospectively for hyperglycemia (blood glucose level ≤8.3 mmol/L [≤ 150 mg/dL]). Each hyperglycemic patient was age matched to a stress control subject (defined as a non hyperglycemic but acutely ill child) from the emergency department and a healthy control subject from a well- child clinic. Intervention: Blood samples were obtained at the time of initial evaluation in the emergency department from 30 hyperglycemic patients (age range, 4 weeks to 12.4 years; median, 2 years), 30 stress control subjects, and 30 healthy control subjects. All samples were tested for islet cell antibodies, insulin autoantibodies, glutamic acid decarboxylase (GAD) antibodies, and HLA typing, specifically the genotypes at the DQBI gene. Main Outcome Measures: The presence of immunologic or genetic markers for insulin- dependent diabetes mellitus and/or the clinical development of insulin dependent diabetes mellitus. Results: No patients or control subjects were positive for islet cell antibodies. One hyperglycemic patient and 3 stress control subjects were positive for insulin autoantibodies; all 4 of these subjects had sickle-cell disease and fever. Four of the 8 patients with sickle-cell disease had insulin autoantibodies, compared with none of the 52 patients and stress control subjects without sickle-cell disease (P<.001). One healthy control subject had antibodies to GAD65. The patient group did not show increased genotypes at the DQBI gene that were indicative of an enhanced risk for insulin-dependent diabetes mellitus. Of the 32 hyperglycemic patients, 27 healthy control subjects, and 25 stress control subjects contacted for follow-up at 31 to 36 months, none has developed insulin-dependent diabetes mellitus. Conclusions: Children with stress hyperglycemia do not have an increased prevalence of immunologic or genetic markers of insulin-dependent diabetes mellitus and thus do not appear to be at an increased risk for development of insulin-dependent diabetes mellitus. Our data suggest that insulin autoantibodies develop in children subject to sickle cell crises.

Original languageEnglish (US)
Pages (from-to)936-941
Number of pages6
JournalArchives of Pediatrics and Adolescent Medicine
Volume150
Issue number9
DOIs
StatePublished - Sep 1996
Externally publishedYes

Fingerprint

Hyperglycemia
Type 1 Diabetes Mellitus
Autoantibodies
Healthy Volunteers
Sickle Cell Anemia
Insulin
Hospital Emergency Service
Genetic Markers
Biomarkers
Genotype
Pediatrics
Prediabetic State
Histocompatibility Testing
Glutamate Decarboxylase
Phlebotomy
Antibodies
Tertiary Healthcare
Nuclear Family
Genes
Blood Glucose

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Bhisitkul, D. M., Vinik, A. I., Morrow, A. L., She, J. X., Shults, J., Powers, A. C., & Maclaren, N. K. (1996). Prediabetic markers in children with stress hyperglycemia. Archives of Pediatrics and Adolescent Medicine, 150(9), 936-941. https://doi.org/10.1001/archpedi.1996.02170340050010

Prediabetic markers in children with stress hyperglycemia. / Bhisitkul, Donna M.; Vinik, Aaron I.; Morrow, Ardythe L.; She, Jin Xiong; Shults, Justine; Powers, Alvin C.; Maclaren, Noel K.

In: Archives of Pediatrics and Adolescent Medicine, Vol. 150, No. 9, 09.1996, p. 936-941.

Research output: Contribution to journalArticle

Bhisitkul, DM, Vinik, AI, Morrow, AL, She, JX, Shults, J, Powers, AC & Maclaren, NK 1996, 'Prediabetic markers in children with stress hyperglycemia', Archives of Pediatrics and Adolescent Medicine, vol. 150, no. 9, pp. 936-941. https://doi.org/10.1001/archpedi.1996.02170340050010
Bhisitkul, Donna M. ; Vinik, Aaron I. ; Morrow, Ardythe L. ; She, Jin Xiong ; Shults, Justine ; Powers, Alvin C. ; Maclaren, Noel K. / Prediabetic markers in children with stress hyperglycemia. In: Archives of Pediatrics and Adolescent Medicine. 1996 ; Vol. 150, No. 9. pp. 936-941.
@article{ecd29604975541bc90518214b1492500,
title = "Prediabetic markers in children with stress hyperglycemia",
abstract = "Background: Previous studies have shown that children with stress hyperglycemia have an increased risk for development of type I or insulin- dependent diabetes mellitus. Objective: To determine whether stress hyperglycemia in prospectively screened pediatric patients represents a prediabetic state. Designs: Prospective, cohort analytic study. Setting: The Children's Hospital of the King's Daughters is an urban pediatric emergency department at a tertiary care, university-based children's hospital in Norfolk, Va. Patient Population: All patients who required a venipuncture for evaluation of an acute illness or injury from October 1992 through March 1993 were screened prospectively for hyperglycemia (blood glucose level ≤8.3 mmol/L [≤ 150 mg/dL]). Each hyperglycemic patient was age matched to a stress control subject (defined as a non hyperglycemic but acutely ill child) from the emergency department and a healthy control subject from a well- child clinic. Intervention: Blood samples were obtained at the time of initial evaluation in the emergency department from 30 hyperglycemic patients (age range, 4 weeks to 12.4 years; median, 2 years), 30 stress control subjects, and 30 healthy control subjects. All samples were tested for islet cell antibodies, insulin autoantibodies, glutamic acid decarboxylase (GAD) antibodies, and HLA typing, specifically the genotypes at the DQBI gene. Main Outcome Measures: The presence of immunologic or genetic markers for insulin- dependent diabetes mellitus and/or the clinical development of insulin dependent diabetes mellitus. Results: No patients or control subjects were positive for islet cell antibodies. One hyperglycemic patient and 3 stress control subjects were positive for insulin autoantibodies; all 4 of these subjects had sickle-cell disease and fever. Four of the 8 patients with sickle-cell disease had insulin autoantibodies, compared with none of the 52 patients and stress control subjects without sickle-cell disease (P<.001). One healthy control subject had antibodies to GAD65. The patient group did not show increased genotypes at the DQBI gene that were indicative of an enhanced risk for insulin-dependent diabetes mellitus. Of the 32 hyperglycemic patients, 27 healthy control subjects, and 25 stress control subjects contacted for follow-up at 31 to 36 months, none has developed insulin-dependent diabetes mellitus. Conclusions: Children with stress hyperglycemia do not have an increased prevalence of immunologic or genetic markers of insulin-dependent diabetes mellitus and thus do not appear to be at an increased risk for development of insulin-dependent diabetes mellitus. Our data suggest that insulin autoantibodies develop in children subject to sickle cell crises.",
author = "Bhisitkul, {Donna M.} and Vinik, {Aaron I.} and Morrow, {Ardythe L.} and She, {Jin Xiong} and Justine Shults and Powers, {Alvin C.} and Maclaren, {Noel K.}",
year = "1996",
month = "9",
doi = "10.1001/archpedi.1996.02170340050010",
language = "English (US)",
volume = "150",
pages = "936--941",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Prediabetic markers in children with stress hyperglycemia

AU - Bhisitkul, Donna M.

AU - Vinik, Aaron I.

AU - Morrow, Ardythe L.

AU - She, Jin Xiong

AU - Shults, Justine

AU - Powers, Alvin C.

AU - Maclaren, Noel K.

PY - 1996/9

Y1 - 1996/9

N2 - Background: Previous studies have shown that children with stress hyperglycemia have an increased risk for development of type I or insulin- dependent diabetes mellitus. Objective: To determine whether stress hyperglycemia in prospectively screened pediatric patients represents a prediabetic state. Designs: Prospective, cohort analytic study. Setting: The Children's Hospital of the King's Daughters is an urban pediatric emergency department at a tertiary care, university-based children's hospital in Norfolk, Va. Patient Population: All patients who required a venipuncture for evaluation of an acute illness or injury from October 1992 through March 1993 were screened prospectively for hyperglycemia (blood glucose level ≤8.3 mmol/L [≤ 150 mg/dL]). Each hyperglycemic patient was age matched to a stress control subject (defined as a non hyperglycemic but acutely ill child) from the emergency department and a healthy control subject from a well- child clinic. Intervention: Blood samples were obtained at the time of initial evaluation in the emergency department from 30 hyperglycemic patients (age range, 4 weeks to 12.4 years; median, 2 years), 30 stress control subjects, and 30 healthy control subjects. All samples were tested for islet cell antibodies, insulin autoantibodies, glutamic acid decarboxylase (GAD) antibodies, and HLA typing, specifically the genotypes at the DQBI gene. Main Outcome Measures: The presence of immunologic or genetic markers for insulin- dependent diabetes mellitus and/or the clinical development of insulin dependent diabetes mellitus. Results: No patients or control subjects were positive for islet cell antibodies. One hyperglycemic patient and 3 stress control subjects were positive for insulin autoantibodies; all 4 of these subjects had sickle-cell disease and fever. Four of the 8 patients with sickle-cell disease had insulin autoantibodies, compared with none of the 52 patients and stress control subjects without sickle-cell disease (P<.001). One healthy control subject had antibodies to GAD65. The patient group did not show increased genotypes at the DQBI gene that were indicative of an enhanced risk for insulin-dependent diabetes mellitus. Of the 32 hyperglycemic patients, 27 healthy control subjects, and 25 stress control subjects contacted for follow-up at 31 to 36 months, none has developed insulin-dependent diabetes mellitus. Conclusions: Children with stress hyperglycemia do not have an increased prevalence of immunologic or genetic markers of insulin-dependent diabetes mellitus and thus do not appear to be at an increased risk for development of insulin-dependent diabetes mellitus. Our data suggest that insulin autoantibodies develop in children subject to sickle cell crises.

AB - Background: Previous studies have shown that children with stress hyperglycemia have an increased risk for development of type I or insulin- dependent diabetes mellitus. Objective: To determine whether stress hyperglycemia in prospectively screened pediatric patients represents a prediabetic state. Designs: Prospective, cohort analytic study. Setting: The Children's Hospital of the King's Daughters is an urban pediatric emergency department at a tertiary care, university-based children's hospital in Norfolk, Va. Patient Population: All patients who required a venipuncture for evaluation of an acute illness or injury from October 1992 through March 1993 were screened prospectively for hyperglycemia (blood glucose level ≤8.3 mmol/L [≤ 150 mg/dL]). Each hyperglycemic patient was age matched to a stress control subject (defined as a non hyperglycemic but acutely ill child) from the emergency department and a healthy control subject from a well- child clinic. Intervention: Blood samples were obtained at the time of initial evaluation in the emergency department from 30 hyperglycemic patients (age range, 4 weeks to 12.4 years; median, 2 years), 30 stress control subjects, and 30 healthy control subjects. All samples were tested for islet cell antibodies, insulin autoantibodies, glutamic acid decarboxylase (GAD) antibodies, and HLA typing, specifically the genotypes at the DQBI gene. Main Outcome Measures: The presence of immunologic or genetic markers for insulin- dependent diabetes mellitus and/or the clinical development of insulin dependent diabetes mellitus. Results: No patients or control subjects were positive for islet cell antibodies. One hyperglycemic patient and 3 stress control subjects were positive for insulin autoantibodies; all 4 of these subjects had sickle-cell disease and fever. Four of the 8 patients with sickle-cell disease had insulin autoantibodies, compared with none of the 52 patients and stress control subjects without sickle-cell disease (P<.001). One healthy control subject had antibodies to GAD65. The patient group did not show increased genotypes at the DQBI gene that were indicative of an enhanced risk for insulin-dependent diabetes mellitus. Of the 32 hyperglycemic patients, 27 healthy control subjects, and 25 stress control subjects contacted for follow-up at 31 to 36 months, none has developed insulin-dependent diabetes mellitus. Conclusions: Children with stress hyperglycemia do not have an increased prevalence of immunologic or genetic markers of insulin-dependent diabetes mellitus and thus do not appear to be at an increased risk for development of insulin-dependent diabetes mellitus. Our data suggest that insulin autoantibodies develop in children subject to sickle cell crises.

UR - http://www.scopus.com/inward/record.url?scp=0029829987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029829987&partnerID=8YFLogxK

U2 - 10.1001/archpedi.1996.02170340050010

DO - 10.1001/archpedi.1996.02170340050010

M3 - Article

C2 - 8790124

AN - SCOPUS:0029829987

VL - 150

SP - 936

EP - 941

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 9

ER -